{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:51:31Z","timestamp":1782924691781,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MINECO-FEDER","award":["PSI2012-31660"],"award-info":[{"award-number":["PSI2012-31660"]}]},{"name":"MINECO-FEDER","award":["PSI2015-70037-R"],"award-info":[{"award-number":["PSI2015-70037-R"]}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017\/SGR\/106;717"],"award-info":[{"award-number":["2017\/SGR\/106;717"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.neuropharm.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T09:57:20Z","timestamp":1536314240000},"page":"10-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Reduced cortical serotonin 5-HT2A receptor binding and glutamate activity in high compulsive drinker rats"],"prefix":"10.1016","volume":"143","author":[{"given":"Santiago","family":"Mora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Merch\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vilchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7940-6246","authenticated-orcid":false,"given":"Susana","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Bue","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Ultved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Campa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Su\u00f1ol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7950-2086","authenticated-orcid":false,"given":"Pilar","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7336-6167","authenticated-orcid":false,"given":"Margarita","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.09.004_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0165-0173(02)00182-0","article-title":"Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei","volume":"39","author":"Adell","year":"2002","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-015-3963-5","article-title":"The role of 5-HT2C receptors in touchscreen visual reversal learning in the rat: a cross-site study","volume":"232","author":"Alsi\u00f6","year":"2015","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s12035-013-8472-0","article-title":"Regulating prefrontal cortex activation: an emerging role for the 5-HT2A serotonin receptor in the modulation of emotion-based actions","volume":"48","author":"Aznar","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neubiorev.2016.02.008","article-title":"The 5-HT2A serotonin receptor in executive function: implications for neuropsychiatric and neurodegenerative diseases","volume":"64","author":"Aznar","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib6","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/npp.2014.335","article-title":"Markers of serotonergic function in the orbitofrontal cortex and dorsal raph\u00e9 nucleus predict individual variation in spatial-discrimination serial reversal learning","volume":"40","author":"Barlow","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib7","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1460-9568.2003.02829.x","article-title":"In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs","volume":"18","author":"Bortolozzi","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1523\/JNEUROSCI.4312-09.2010","article-title":"Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific","volume":"30","author":"Boulougouris","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib9","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/sj.npp.1301584","article-title":"Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats","volume":"33","author":"Boulougouris","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2011.01.020","article-title":"Impulsivity, compulsivity, and top-down cognitive control","volume":"69","author":"Dalley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib11","series-title":"The Impulsive Client: Theory, Research, and Treatment","first-page":"23","article-title":"A neurodevelopmental view of impulsivity","author":"Daruna","year":"1993"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2007.04768.x","article-title":"Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT2A receptors in human and monkey prefrontal cortex","volume":"103","author":"De Almeida","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuropharm.2013.02.005","article-title":"The two faces of the pharmacological interaction of mGlu2 and 5-HT2A - relevance of receptor heterocomplexes and interaction through functional brain pathways","volume":"70","author":"Delille","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF02245706","article-title":"Effect of clozapine upon schedule-induced polydipsia (SIP) resembles neither the actions of dopamine D1 nor D2 blockade","volume":"113","author":"Didriksen","year":"1993","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1126\/science.133.3447.195","article-title":"Production of polydipsia in normal rats by an intermittent food schedule","volume":"133","author":"Falk","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/npp.2009.185","article-title":"Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review","volume":"35","author":"Fineberg","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib17","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/npp.2015.46","article-title":"Individual differences in impulsive action reflect variation in the cortical serotonin 5-HT2A receptor system","volume":"40","author":"Fink","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib18","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s12035-017-0457-y","article-title":"Differences in 5-HT2A and mGlu2 receptor expression levels and repressive epigenetic modifications at the 5-HT2A promoter region in the roman low- (RLA-I) and high- (RHA-I) avoidance rat strains","volume":"55","author":"Fomsgaard","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pnpbp.2015.03.012","article-title":"A response strategy predicts acquisition of schedule-induced polydipsia in rats","volume":"61","author":"Gregory","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","article-title":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","volume":"277","author":"Halberstadt","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib22","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00213-013-3345-9","article-title":"The amphetamine sensitization model of schizophrenia symptoms and its effects on schedule-induced polydipsia in the rat","volume":"231","author":"Hawken","year":"2014","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pbb.2003.09.020","article-title":"Acceleration of onset of action in schedule-induced polydipsia: combinations of SSRI and 5-HT1A and 5-HT1B receptor antagonists","volume":"77","author":"Hogg","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S1092852900002467","article-title":"Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues","volume":"12","author":"Hollander","year":"2007","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00213-007-0921-x","article-title":"5-HT2A receptor density is decreased in the at-risk mental state","volume":"195","author":"Hurlemann","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuroscience.2013.12.063","article-title":"5-HT(2A) and mGlu2 receptor binding levels are related to differences in impulsive behavior in the Roman Low- (RLA) and High- (RHA) avoidance rat strains","volume":"263","author":"Klein","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib27","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/cercor\/10.10.974","article-title":"Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat","volume":"10","author":"Lambe","year":"2000","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib28","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.npp.1301356","article-title":"Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat","volume":"32","author":"L\u00f3pez-Gil","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2174\/1570159X15666170320104237","article-title":"Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder","volume":"15","author":"Marinova","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0091-3057(01)00713-4","article-title":"Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety","volume":"71","author":"Martin","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3565(24)37669-4","article-title":"5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential","volume":"286","author":"Martin","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-017-4819-y","article-title":"Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia","volume":"235","author":"Mart\u00edn-Gonz\u00e1lez","year":"2018","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib33","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1523\/JNEUROSCI.21-24-09856.2001","article-title":"Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism","volume":"21","author":"Mart\u00edn-Ruiz","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-3565(25)23811-3","article-title":"Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists","volume":"271","author":"Mittleman","year":"1994","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00213-011-2570-3","article-title":"Schedule-induced polydipsia as a model of compulsive behavior: neuropharmacological and neuroendocrine bases","volume":"219","author":"Moreno","year":"2012","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/npp.2009.224","article-title":"Impulsivity characterization in the Roman high- and low-avoidance rat strains: behavioral and neurochemical differences","volume":"35","author":"Moreno","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00213-013-3010-3","article-title":"Divergent effects of D\u2082\/\u2083 receptor activation in the nucleus accumbens core and shell on impulsivity and locomotor activity in high and low impulsive rats","volume":"228","author":"Moreno","year":"2013","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00213-014-3699-7","article-title":"Activation of serotonin 5-HT2A receptors inhibits high compulsive drinking on schedule-induced polydipsia","volume":"232","author":"Navarro","year":"2015","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib39","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/schbul\/sbw141","article-title":"Behavioral biomarkers of schizophrenia in high drinker rats: a potential endophenotype of compulsive neuropsychiatric disorders","volume":"43","author":"Navarro","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/syn.20240","article-title":"Immunodetection of the serotonin transporter protein is a more valid marker for serotonergic fibers than serotonin","volume":"59","author":"Nielsen","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib41","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbr.2010.10.010","article-title":"Individual differences in schedule-induced polydipsia: neuroanatomical dopamine divergences","volume":"217","author":"Pell\u00f3n","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder","volume":"42","author":"Perani","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib44","first-page":"1","article-title":"Schedule-induced polydipsia: a rat model of obsessive-compulsive disorder","volume":"27","author":"Platt","year":"2008","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/mp.2015.32","article-title":"Whole-genome association analysis of treatment response in obsessive-compulsive disorder","volume":"21","author":"Qin","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archgenpsychiatry.2009.176","article-title":"Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia","volume":"67","author":"Rasmussen","year":"2010","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tics.2011.11.009","article-title":"Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry","volume":"16","author":"Robbins","year":"2012","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib48","series-title":"Handbook of Behavioral Neuroscience","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1569-7339(10)70093-X","article-title":"Role of central serotonin in impulsivity and compulsivity: comparative studies in experimental animals and humans","author":"Robbins","year":"2010"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-007-0710-6","article-title":"Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents","volume":"192","author":"Rosenzweig-Lipson","year":"2007","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib50","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neubiorev.2014.06.005","article-title":"Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies","volume":"45","author":"Selvaraj","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib52","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.biopsych.2011.06.023","article-title":"Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL100907","volume":"70","author":"Simpson","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib53","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00213-015-4150-4","article-title":"Inhibition of hippocampal plasticity in rats performing contrafreeloading for water under repeated administrations of pramipexole","volume":"233","author":"Schepisi","year":"2016","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib54","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/mp.2012.76","article-title":"Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0091-3057(92)90130-8","article-title":"Effects of D1 and D2 dopamine antagonists on behavior of polydipsic rats","volume":"42","author":"Todd","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pscychresns.2011.06.006","article-title":"Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder","volume":"201","author":"Vermeire","year":"2012","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1017\/S1092852900002479","article-title":"Neurobiology of obsessive-compulsive disorder: serotonin and beyond","volume":"12","author":"Westenberg","year":"2007","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib58","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/FBP.0b013e32834d6279","article-title":"Impulsive behaviour in rats induced by intracortical DOI infusions is antagonized by co-administration of an mGlu2\/3 receptor agonist","volume":"22","author":"Wischhof","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.004_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02244910","article-title":"Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder","volume":"112","author":"Woods","year":"1993","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib60","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1517\/13543784.6.10.1369","article-title":"Animal models with potential applications for screening compounds for the treatment of obsessive-compulsive disorder","volume":"6","author":"Woods-Kettelberger","year":"1997","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib61","series-title":"The Global Burden of Disease:2004 Update. Geneve: Switzerland","author":"World Health Organization (WHO)","year":"2008"},{"key":"10.1016\/j.neuropharm.2018.09.004_bib62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/15622970009150571","article-title":"Obsessive compulsive disorder: serotonin and beyond","volume":"2","author":"Zohar","year":"2000","journal-title":"World J. Biol. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T23:44:10Z","timestamp":1751845450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818306270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":62,"alternative-id":["S0028390818306270"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.004","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced cortical serotonin 5-HT2A receptor binding and glutamate activity in high compulsive drinker rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}